Showing results (261-270 of 319) with videos related to
Sort By:
Pageof 32
Haematologica|November 27, 2025
Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphomaAdam J Olszewski, Thomas A Ollila, Dai Chihara, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 1986
CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacologyM J Ryan, F A Bjork, D M Cohen, et al.The Journal of Pharmacology and Experimental Therapeutics|February 1, 1984
Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitorM J Ryan, D M Boucher, D M Cohen, et al.Journal of Oncology Practice|February 25, 2016
Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer ProgramKalyan C Mantripragada, Adam J Olszewski, Andrew Schumacher, et al.Journal of Geriatric Oncology|April 27, 2024
Predictors of high-intensity care at the end of life among older adults with solid tumors: A population-based studyCourtney E Baird, Elizabeth Wulff-Burchfield, Pamela C Egan, et al.Cancers|March 28, 2025
Predictors and Drivers of End-of-Life Medicare Spending Among Older Adults with Solid Tumors: A Population-Based StudyCourtney E Baird, Elizabeth Wulff-Burchfield, Pamela C Egan, et al.Cancer Biology & Therapy|July 11, 2022
Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphomaAndrew Hsu, Kelsey E Huntington, Andre De Souza, et al.Cancer|July 11, 2022
Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignanciesThomas A Ollila, Rebecca H Masel, John L Reagan, et al.Experimental Hematology & Oncology|May 14, 2025
Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite studyNarendranath Epperla, Geoffrey Shouse, Natalie S Grover, et al.Cancer Research Communications|November 13, 2025
BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)Andre L De Souza, Matthew J Hadfield, Shaolei Lu, et al.Pageof 32